Amoxicillin-Clavulanate
Amoxicillin-clavulanate showed no clear evidence of different clinical resolution compared with other antibiotics. A later trial found intravenous amoxicillin-clavulanate was non-inferior to ampicillin-sulbactam in adult CAP. The review in…
1 sources - 5 claims
Amoxicillin-clavulanate showed no clear evidence of different clinical resolution compared with other antibiotics. A later trial found intravenous amoxicillin-clavulanate was non-inferior to ampicillin-sulbactam in adult CAP. The review included 17 amoxicillin-clavulanate trials with 5,432 patients. All amoxicillin-clavulanate trials reported clinical resolution as their primary outcome. WHO and AWaRe guidance identify amoxicillin-clavulanate as a second-choice option for bacterial CAP.